<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://142-54-23-223.fusionmedialtd.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 16 Jul 2026 16:26:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://142-54-23-223.fusionmedialtd.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  4          GoodRx Holdings, Inc.     For: Jul 15  Filed by: Barnes Wendy Lynn</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jul+15++Filed+by%3A+Barnes+Wendy+Lynn/26779981.html</link>
   <description>si-local-file:///var/storage/secattach/20260716/26779981.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jul+15++Filed+by%3A+Barnes+Wendy+Lynn/26779981.html</guid>
   <pubDate>Thu, 16 Jul 2026 16:26:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48546299</category>
   	  </item>
  <item>
   <title>Form  4          GoodRx Holdings, Inc.     For: Jul 15  Filed by: Barnes Wendy Lynn</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jul+15++Filed+by%3A+Barnes+Wendy+Lynn/26779981.html</link>
   <description>si-local-file:///var/storage/secattach/20260716/26779981.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jul+15++Filed+by%3A+Barnes+Wendy+Lynn/26779981.html</guid>
   <pubDate>Thu, 16 Jul 2026 16:26:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48546299</category>
   	  </item>
  <item>
   <title>Form  4          GoodRx Holdings, Inc.     For: Jul 15  Filed by: McGinnis Christopher A</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jul+15++Filed+by%3A+McGinnis+Christopher+A/26779990.html</link>
   <description>si-local-file:///var/storage/secattach/20260716/26779990.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jul+15++Filed+by%3A+McGinnis+Christopher+A/26779990.html</guid>
   <pubDate>Thu, 16 Jul 2026 16:26:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48546299</category>
   	  </item>
  <item>
   <title>Form  4          GoodRx Holdings, Inc.     For: Jul 15  Filed by: McGinnis Christopher A</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jul+15++Filed+by%3A+McGinnis+Christopher+A/26779990.html</link>
   <description>si-local-file:///var/storage/secattach/20260716/26779990.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jul+15++Filed+by%3A+McGinnis+Christopher+A/26779990.html</guid>
   <pubDate>Thu, 16 Jul 2026 16:26:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48546299</category>
   	  </item>
  <item>
   <title>Form  4          GoodRx Holdings, Inc.     For: Jul 15  Filed by: Chan Thomas (TC)</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jul+15++Filed+by%3A+Chan+Thomas+%28TC%29/26779971.html</link>
   <description>si-local-file:///var/storage/secattach/20260716/26779971.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jul+15++Filed+by%3A+Chan+Thomas+%28TC%29/26779971.html</guid>
   <pubDate>Thu, 16 Jul 2026 16:25:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48546299</category>
   	  </item>
  <item>
   <title>Form  4          GoodRx Holdings, Inc.     For: Jul 15  Filed by: Chan Thomas (TC)</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jul+15++Filed+by%3A+Chan+Thomas+%28TC%29/26779971.html</link>
   <description>si-local-file:///var/storage/secattach/20260716/26779971.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jul+15++Filed+by%3A+Chan+Thomas+%28TC%29/26779971.html</guid>
   <pubDate>Thu, 16 Jul 2026 16:25:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48546299</category>
   	  </item>
  <item>
   <title>GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call</title>
   <link>http://www.streetinsider.com/Press+Releases/GoodRx+Announces+Date+for+Second+Quarter+2026+Earnings+Release+and+Conference+Call/26753193.html</link>
   <description>
&lt;p&gt;    SANTA MONICA, Calif.--(BUSINESS WIRE)--
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for prescription savings in the U.S., today announced it will release its second quarter 2026 financial results after U.S. markets close on Wednesday, August 5, 2026. GoodRx management will also hold a conference call and webcast the following morning, Thursday, August 6, 2026 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlook.

&lt;/p&gt;&lt;p&gt;
To access the conference call, please pre-register using this &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fregister-conf.media-server.com%2Fregister%2FBI2d7e976f9edd481db1351e5bb1902f6a&amp;amp;esheet=54567464&amp;amp;newsitemid=20260709274086&amp;amp;lan=en-US&amp;amp;anchor=link&amp;amp;index=1&amp;amp;md5=aa89df4cd3e9fd2f71f8d71ffa50076b&quot; shape=&quot;rect&quot;&gt;link&lt;/a&gt;. Registrants will receive a confirmation with dial-in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/GoodRx+Announces+Date+for+Second+Quarter+2026+Earnings+Release+and+Conference+Call/26753193.html</guid>
   <pubDate>Thu, 09 Jul 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48546299</category>
   	  </item>
  <item>
   <title>GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call</title>
   <link>http://www.streetinsider.com/Press+Releases/GoodRx+Announces+Date+for+Second+Quarter+2026+Earnings+Release+and+Conference+Call/26753193.html</link>
   <description>
&lt;p&gt;    SANTA MONICA, Calif.--(BUSINESS WIRE)--
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for prescription savings in the U.S., today announced it will release its second quarter 2026 financial results after U.S. markets close on Wednesday, August 5, 2026. GoodRx management will also hold a conference call and webcast the following morning, Thursday, August 6, 2026 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlook.

&lt;/p&gt;&lt;p&gt;
To access the conference call, please pre-register using this &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fregister-conf.media-server.com%2Fregister%2FBI2d7e976f9edd481db1351e5bb1902f6a&amp;amp;esheet=54567464&amp;amp;newsitemid=20260709274086&amp;amp;lan=en-US&amp;amp;anchor=link&amp;amp;index=1&amp;amp;md5=aa89df4cd3e9fd2f71f8d71ffa50076b&quot; shape=&quot;rect&quot;&gt;link&lt;/a&gt;. Registrants will receive a confirmation with dial-in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/GoodRx+Announces+Date+for+Second+Quarter+2026+Earnings+Release+and+Conference+Call/26753193.html</guid>
   <pubDate>Thu, 09 Jul 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48546299</category>
   	  </item>
  <item>
   <title>GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call</title>
   <link>http://www.streetinsider.com/Business+Wire/GoodRx+Announces+Date+for+Second+Quarter+2026+Earnings+Release+and+Conference+Call/26753193.html</link>
   <description>
&lt;p&gt;    SANTA MONICA, Calif.--(BUSINESS WIRE)--
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for prescription savings in the U.S., today announced it will release its second quarter 2026 financial results after U.S. markets close on Wednesday, August 5, 2026. GoodRx management will also hold a conference call and webcast the following morning, Thursday, August 6, 2026 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlook.

&lt;/p&gt;&lt;p&gt;
To access the conference call, please pre-register using this &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fregister-conf.media-server.com%2Fregister%2FBI2d7e976f9edd481db1351e5bb1902f6a&amp;amp;esheet=54567464&amp;amp;newsitemid=20260709274086&amp;amp;lan=en-US&amp;amp;anchor=link&amp;amp;index=1&amp;amp;md5=aa89df4cd3e9fd2f71f8d71ffa50076b&quot; shape=&quot;rect&quot;&gt;link&lt;/a&gt;. Registrants will receive a confirmation with dial-in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/GoodRx+Announces+Date+for+Second+Quarter+2026+Earnings+Release+and+Conference+Call/26753193.html</guid>
   <pubDate>Thu, 09 Jul 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48546299</category>
   	  </item>
  <item>
   <title>GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call</title>
   <link>http://www.streetinsider.com/Business+Wire/GoodRx+Announces+Date+for+Second+Quarter+2026+Earnings+Release+and+Conference+Call/26753193.html</link>
   <description>
&lt;p&gt;    SANTA MONICA, Calif.--(BUSINESS WIRE)--
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for prescription savings in the U.S., today announced it will release its second quarter 2026 financial results after U.S. markets close on Wednesday, August 5, 2026. GoodRx management will also hold a conference call and webcast the following morning, Thursday, August 6, 2026 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlook.

&lt;/p&gt;&lt;p&gt;
To access the conference call, please pre-register using this &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fregister-conf.media-server.com%2Fregister%2FBI2d7e976f9edd481db1351e5bb1902f6a&amp;amp;esheet=54567464&amp;amp;newsitemid=20260709274086&amp;amp;lan=en-US&amp;amp;anchor=link&amp;amp;index=1&amp;amp;md5=aa89df4cd3e9fd2f71f8d71ffa50076b&quot; shape=&quot;rect&quot;&gt;link&lt;/a&gt;. Registrants will receive a confirmation with dial-in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/GoodRx+Announces+Date+for+Second+Quarter+2026+Earnings+Release+and+Conference+Call/26753193.html</guid>
   <pubDate>Thu, 09 Jul 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48546299</category>
   	  </item>
  <item>
   <title>Form  8-K        GoodRx Holdings, Inc.     For: Jun 16</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jun+16/26666341.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26666341.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jun+16/26666341.html</guid>
   <pubDate>Thu, 18 Jun 2026 16:19:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48546299</category>
   	  </item>
  <item>
   <title>Form  8-K        GoodRx Holdings, Inc.     For: Jun 16</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jun+16/26666341.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26666341.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jun+16/26666341.html</guid>
   <pubDate>Thu, 18 Jun 2026 16:19:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48546299</category>
   	  </item>
  <item>
   <title>Oral Wegovy reaches 33% of total prescriptions by May</title>
   <link>http://www.streetinsider.com/General+News/Oral+Wegovy+reaches+33%25+of+total+prescriptions+by+May/26662105.html</link>
   <description>&lt;p&gt;Investing.com -- Oral Wegovy accounted for approximately 33% of total Wegovy prescriptions in May, according to a Bank of America report released Thursday. The oral formulation reached 159,000 weekly total prescriptions in the week ending June 5, 2026.&lt;/p&gt;&lt;p&gt;The oral version of Wegovy launched in early January and has grown rapidly since its introduction. Weekly new prescriptions for oral Wegovy represented 40% of total new Wegovy prescriptions in the week ending June 5, 2026. The mix of oral prescriptions has stabilized in the low-30% range over recent weeks after initial rapid growth.&lt;/p&gt;&lt;p&gt;The broader GLP-1 drug category showed weekly total prescription growth</description>
   <guid isPermaLink="true">http://www.streetinsider.com/General+News/Oral+Wegovy+reaches+33%25+of+total+prescriptions+by+May/26662105.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:47:49 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HIMS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVO</category>
   	  </item>
  <item>
   <title>Oral Wegovy reaches 33% of total prescriptions by May</title>
   <link>http://www.streetinsider.com/General+News/Oral+Wegovy+reaches+33%25+of+total+prescriptions+by+May/26662105.html</link>
   <description>&lt;p&gt;Investing.com -- Oral Wegovy accounted for approximately 33% of total Wegovy prescriptions in May, according to a Bank of America report released Thursday. The oral formulation reached 159,000 weekly total prescriptions in the week ending June 5, 2026.&lt;/p&gt;&lt;p&gt;The oral version of Wegovy launched in early January and has grown rapidly since its introduction. Weekly new prescriptions for oral Wegovy represented 40% of total new Wegovy prescriptions in the week ending June 5, 2026. The mix of oral prescriptions has stabilized in the low-30% range over recent weeks after initial rapid growth.&lt;/p&gt;&lt;p&gt;The broader GLP-1 drug category showed weekly total prescription growth</description>
   <guid isPermaLink="true">http://www.streetinsider.com/General+News/Oral+Wegovy+reaches+33%25+of+total+prescriptions+by+May/26662105.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:47:49 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HIMS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVO</category>
   	  </item>
  <item>
   <title>Oral Wegovy reaches 33% of total prescriptions by May</title>
   <link>http://www.streetinsider.com/General+News/Oral+Wegovy+reaches+33%25+of+total+prescriptions+by+May/26662105.html</link>
   <description>&lt;p&gt;Investing.com -- Oral Wegovy accounted for approximately 33% of total Wegovy prescriptions in May, according to a Bank of America report released Thursday. The oral formulation reached 159,000 weekly total prescriptions in the week ending June 5, 2026.&lt;/p&gt;&lt;p&gt;The oral version of Wegovy launched in early January and has grown rapidly since its introduction. Weekly new prescriptions for oral Wegovy represented 40% of total new Wegovy prescriptions in the week ending June 5, 2026. The mix of oral prescriptions has stabilized in the low-30% range over recent weeks after initial rapid growth.&lt;/p&gt;&lt;p&gt;The broader GLP-1 drug category showed weekly total prescription growth</description>
   <guid isPermaLink="true">http://www.streetinsider.com/General+News/Oral+Wegovy+reaches+33%25+of+total+prescriptions+by+May/26662105.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:47:49 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HIMS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVO</category>
   	  </item>
  <item>
   <title>Oral Wegovy reaches 33% of total prescriptions by May</title>
   <link>http://www.streetinsider.com/General+News/Oral+Wegovy+reaches+33%25+of+total+prescriptions+by+May/26662105.html</link>
   <description>&lt;p&gt;Investing.com -- Oral Wegovy accounted for approximately 33% of total Wegovy prescriptions in May, according to a Bank of America report released Thursday. The oral formulation reached 159,000 weekly total prescriptions in the week ending June 5, 2026.&lt;/p&gt;&lt;p&gt;The oral version of Wegovy launched in early January and has grown rapidly since its introduction. Weekly new prescriptions for oral Wegovy represented 40% of total new Wegovy prescriptions in the week ending June 5, 2026. The mix of oral prescriptions has stabilized in the low-30% range over recent weeks after initial rapid growth.&lt;/p&gt;&lt;p&gt;The broader GLP-1 drug category showed weekly total prescription growth</description>
   <guid isPermaLink="true">http://www.streetinsider.com/General+News/Oral+Wegovy+reaches+33%25+of+total+prescriptions+by+May/26662105.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:47:49 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HIMS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVO</category>
   	  </item>
  <item>
   <title>Oral Wegovy reaches 33% of total prescriptions by May</title>
   <link>http://www.streetinsider.com/General+News/Oral+Wegovy+reaches+33%25+of+total+prescriptions+by+May/26662105.html</link>
   <description>&lt;p&gt;Investing.com -- Oral Wegovy accounted for approximately 33% of total Wegovy prescriptions in May, according to a Bank of America report released Thursday. The oral formulation reached 159,000 weekly total prescriptions in the week ending June 5, 2026.&lt;/p&gt;&lt;p&gt;The oral version of Wegovy launched in early January and has grown rapidly since its introduction. Weekly new prescriptions for oral Wegovy represented 40% of total new Wegovy prescriptions in the week ending June 5, 2026. The mix of oral prescriptions has stabilized in the low-30% range over recent weeks after initial rapid growth.&lt;/p&gt;&lt;p&gt;The broader GLP-1 drug category showed weekly total prescription growth</description>
   <guid isPermaLink="true">http://www.streetinsider.com/General+News/Oral+Wegovy+reaches+33%25+of+total+prescriptions+by+May/26662105.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:47:49 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HIMS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVO</category>
   	  </item>
  <item>
   <title>Form  4          GoodRx Holdings, Inc.     For: Jun 16  Filed by: REY-GIRAUD AGNES</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jun+16++Filed+by%3A+REY-GIRAUD+AGNES/26661556.html</link>
   <description>si-local-file:///var/storage/secattach/20260617/26661556.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jun+16++Filed+by%3A+REY-GIRAUD+AGNES/26661556.html</guid>
   <pubDate>Wed, 17 Jun 2026 20:36:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48546299</category>
   	  </item>
  <item>
   <title>Form  4          GoodRx Holdings, Inc.     For: Jun 16  Filed by: REY-GIRAUD AGNES</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jun+16++Filed+by%3A+REY-GIRAUD+AGNES/26661556.html</link>
   <description>si-local-file:///var/storage/secattach/20260617/26661556.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jun+16++Filed+by%3A+REY-GIRAUD+AGNES/26661556.html</guid>
   <pubDate>Wed, 17 Jun 2026 20:36:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48546299</category>
   	  </item>
  <item>
   <title>Form  4          GoodRx Holdings, Inc.     For: Jun 16  Filed by: Kennedy Kelly J.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jun+16++Filed+by%3A+Kennedy+Kelly+J./26661554.html</link>
   <description>si-local-file:///var/storage/secattach/20260617/26661554.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jun+16++Filed+by%3A+Kennedy+Kelly+J./26661554.html</guid>
   <pubDate>Wed, 17 Jun 2026 20:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48546299</category>
   	  </item>
  <item>
   <title>Form  4          GoodRx Holdings, Inc.     For: Jun 16  Filed by: Kennedy Kelly J.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jun+16++Filed+by%3A+Kennedy+Kelly+J./26661554.html</link>
   <description>si-local-file:///var/storage/secattach/20260617/26661554.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jun+16++Filed+by%3A+Kennedy+Kelly+J./26661554.html</guid>
   <pubDate>Wed, 17 Jun 2026 20:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48546299</category>
   	  </item>
  <item>
   <title>Form  4          GoodRx Holdings, Inc.     For: Jun 16  Filed by: Bruehlman Ronald E</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jun+16++Filed+by%3A+Bruehlman+Ronald+E/26661550.html</link>
   <description>si-local-file:///var/storage/secattach/20260617/26661550.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jun+16++Filed+by%3A+Bruehlman+Ronald+E/26661550.html</guid>
   <pubDate>Wed, 17 Jun 2026 20:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48546299</category>
   	  </item>
  <item>
   <title>Form  4          GoodRx Holdings, Inc.     For: Jun 16  Filed by: Bruehlman Ronald E</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jun+16++Filed+by%3A+Bruehlman+Ronald+E/26661550.html</link>
   <description>si-local-file:///var/storage/secattach/20260617/26661550.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jun+16++Filed+by%3A+Bruehlman+Ronald+E/26661550.html</guid>
   <pubDate>Wed, 17 Jun 2026 20:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48546299</category>
   	  </item>
  <item>
   <title>Form  4          GoodRx Holdings, Inc.     For: Jun 16  Filed by: Hirsch Douglas Joseph</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jun+16++Filed+by%3A+Hirsch+Douglas+Joseph/26661551.html</link>
   <description>si-local-file:///var/storage/secattach/20260617/26661551.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jun+16++Filed+by%3A+Hirsch+Douglas+Joseph/26661551.html</guid>
   <pubDate>Wed, 17 Jun 2026 20:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48546299</category>
   	  </item>
  <item>
   <title>Form  4          GoodRx Holdings, Inc.     For: Jun 16  Filed by: Hirsch Douglas Joseph</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jun+16++Filed+by%3A+Hirsch+Douglas+Joseph/26661551.html</link>
   <description>si-local-file:///var/storage/secattach/20260617/26661551.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++GoodRx+Holdings%2C+Inc.+++++For%3A+Jun+16++Filed+by%3A+Hirsch+Douglas+Joseph/26661551.html</guid>
   <pubDate>Wed, 17 Jun 2026 20:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GDRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48546299</category>
   	  </item>
 </channel>
</rss>
